Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-01

FDA Approved: FEBUXOSTAT — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals Limited's original ANDA for febuxostat, a generic version of the gout and hyperuricemia therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEBUXOSTAT (Febuxostat)

Snippet

ORIG AP for FEBUXOSTAT (FEBUXOSTAT)